Symptoms in advanced renal disease: A cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis

被引:186
作者
Murtagh, Fliss E. M. [1 ]
Addington-Hall, Julia M. [2 ]
Edmonds, Polly M. [3 ]
Donohoe, Paul
Carey, Irene [4 ]
Jenkins, Karen [5 ]
Higginson, Irene J. [1 ]
机构
[1] Kings Coll London, Dept Palliat Care Policy & Rehab, UK Weston Educ Ctr, London SE5 9RJ, England
[2] Univ Southampton, Sch Nursing & Midwifery, Southampton, Hants, England
[3] Kings Coll Hosp NHS Fdn, Dept Nephrol, Dept Palliat Care, London, England
[4] Guys & St Thomas NHS Fdn Trust, Dept Palliat Care, London, England
[5] E Kent Hosp NHS Trust, Dept Renal Med, Canterbury, Kent, England
关键词
D O I
10.1089/jpm.2007.0017
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Numbers of patients with stage 5 chronic kidney disease (CKD) managed conservatively (without dialysis) are increasing steadily but prevalence and severity of symptoms in this population are not yet known. Aim: To describe symptom prevalence, symptom severity, and total symptom burden in patients with stage 5 CKD managed conservatively. Method: A cross-sectional survey of patients with stage 5 CKD managed conservatively, in three U. K. renal units. Symptoms were assessed using the patient-completed Memorial Symptom Assessment Scale Short Form (MSAS-SF), with additional renal symptoms. Results: Sixty-six patients were recruited (responserate, 62%), with mean age 82 years (standard deviation [SD]+/- 6.6), and mean estimated glomerular filtration rate 11.2 mL/min (SD +/- 2.8). Symptoms reported by more than one third or 33% of patients were (95% confidence intervals shown in parentheses): lack of energy, 76% (66% - 84%); pruritus, 74% (65% - 82%); drowsiness, 65% (54% - 74%); dyspnea, 61% (50% - 70%); edema, 58% (47% - 66%); pain, 53% (42% - 63%); dry mouth, 50% (39% - 60%); muscle cramps, 50% (39% - 60%); restless legs, 48% (38% - 58%); lack of appetite, 47% (37% - 58%); poor concentration, 44% (34% - 54%); dry skin, 42% (32% - 53%); sleep disturbance, 41% (32% - 51%); and constipation, 35% (26% - 45%). Mean number of symptoms reported on MSAS-SF was 11.58 (SD +/- 5.2), with an additional 2.77 (SD +/- 1.7) renal symptoms. Symptoms were also most severe in the more prevalent symptoms. Pain was an exception, with disproportionately greater severity ( 32% of all patients reported moderate/severe pain). Conclusion: This study demonstrates that patients with stage 5 CKD have considerable symptom control needs, similar to advanced cancer populations, but with different patterns of individual symptoms and severity, particularly pain. Implications for palliative care, hospice, and nephrology services in planning and providing care are discussed.
引用
收藏
页码:1266 / 1276
页数:11
相关论文
共 32 条
  • [1] Age is not the crucial factor in determining how the palliative care needs of people who die from cancer differ from those of people who die from other causes
    Addington-Hall, JM
    Karlsen, S
    [J]. JOURNAL OF PALLIATIVE CARE, 1999, 15 (04) : 13 - 19
  • [2] Palliative performance scale (PPS): A new tool
    Anderson, F
    Downing, GM
    Hill, J
    Casorso, L
    Lerch, N
    [J]. JOURNAL OF PALLIATIVE CARE, 1996, 12 (01) : 5 - 11
  • [3] Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients
    Andreucci, VE
    Fissell, RB
    Bragg-Gresham, JL
    Ethier, J
    Greenwood, R
    Pauly, M
    Wizemann, V
    Port, FK
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (05) : S61 - S67
  • [4] [Anonymous], 2006, USRDS 2006 ANN DAT R
  • [5] Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease
    Barakzoy, Ahmad S.
    Moss, Alvin H.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (11): : 3198 - 3203
  • [6] Conservative treatment to slow deterioration of renal function: Evidence-based recommendations
    Burgess, E
    [J]. KIDNEY INTERNATIONAL, 1999, 55 : S17 - S25
  • [7] Conservative management of end-stage renal failure: Masterly inactivity or benign neglect?
    Burns, A
    [J]. NEPHRON CLINICAL PRACTICE, 2003, 95 (02): : C37 - C39
  • [8] Chang VT, 2000, CANCER, V89, P1162, DOI 10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO
  • [9] 2-Y
  • [10] The family perspective of ESRD deaths
    Cohen, LM
    Germain, MJ
    Woods, AL
    Mirot, A
    Burleson, JA
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) : 154 - 161